06-9469. National Cancer Institute; Notice of Closed Meetings

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Cancer Institute Special Emphasis Panel; Development and Discovery.

Date: February 7-9, 2007.

Time: 5 p.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: Double Tree Rockville, 1750 Rockville Pike, Rockville, MD 20852.

Contact Person: Peter J. Wirth, PhD, Scientific Review Administrator, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 8131, Bethesda, MD 20892-8328. 301-496-7565. [e-mail].

Name of Committee: National Cancer Institute Special Emphasis Panel; SPORE II.

Date: February 13-15, 2007.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Caron Lyman, Scientific Review Administrator, Division of Extramural Activities, National Cancer Institute, National Institutes of Health, 6116 Executive Blvd, Room 8119, Bethesda, MD 20892-8328. 301-451-4761. [e-mail].

(Catalogue of Federal Domestic Assistance Program Nos.93.392, Cancer Construction;93.393, Cancer Cause and Prevention Research;93.394, Cancer Detection and Diagnosis Research;93.395, Cancer Treatment Research;93.396, Cancer Biology Research;93.397, Cancer Centers Support;93.398, Cancer Research Manpower;93.399, Cancer Control, National Institutes of Health, HHS)

Dated: November 20, 2006.

David Clary,

Acting Director, Office of Federal Advisory Committee Policy.